PAVmed Inc (PAVM)

NASDAQ
5.930
+0.060(+1.02%)
  • Volume:
    1,115,176
  • Bid/Ask:
    5.930/5.960
  • Day's Range:
    5.730 - 6.000

PAVM Overview

Prev. Close
5.87
Day's Range
5.73-6
Revenue
-
Open
5.9
52 wk Range
1.63-7.06
EPS
-0.54
Volume
1,115,176
Market Cap
497.34M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
54,368
P/E Ratio
-
Beta
0.31
1-Year Change
187.86%
Shares Outstanding
83,869,061
Next Earnings Date
Nov 18, 2021
What is your sentiment on PAVmed Inc?
or
Market is currently closed. Voting is open during market hours.

PAVmed Inc News

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyStrong BuyStrong BuyStrong BuyStrong Buy
Technical IndicatorsStrong BuyStrong BuyStrong BuyStrong BuyStrong Buy
SummaryStrong BuyStrong BuyStrong BuyStrong BuyStrong Buy

PAVmed Inc Company Profile

PAVmed Inc Company Profile

PAVmed Inc. operates as a medical device company in the United States. The company's lead products include CarpX, a percutaneous device to treat carpal tunnel syndrome; and EsoCheck, an esophageal cell collection device for the early detection of adenocarcinoma of the esophagus and Barrett’s Esophagus (BE). Its product pipeline also comprises EsoGuard, a molecular diagnostic esophageal DNA test; EsoCure, an esophageal ablation device to treat dysplastic BE; PortIO, an implantable intraosseous vascular access device; NextFlo, a disposable infusion platform technology; PortIO, an implantable intraosseous vascular access device; and DisappEAR, a resorbable pediatric ear tube, as well as NextCath and Caldus. The company was formerly known as PAXmed Inc. and changed its name to PAVmed Inc. in April 2015. PAVmed Inc. was incorporated in 2014 and is based in New York, New York.

Read More
  • Yes come
    0
    • come to daddy
      0
  • Come
    0
    Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
    Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.